Joseph W. Goldzieher on the occasion of his 100th birtday

References

• Garcia CR, Pincus G, Rock J. Effects of three 19-nor steroids on human ovulation and menstruation. Am J Obstet Gynecol. 1958;75:82–97.
   PubMed Web of Science ®Google Scholar
• Pincus G, Rock J, Garcia CR, et al. Fertility control with oral medication. Am J Obstet Gynecol. 1958;75:1333–1346.
   PubMed Web of Science ®Google Scholar
• Pincus G. The hormonal control of ovulation and early development. Postgrad Med. 1958;24:654–660.
   PubMedGoogle Scholar
• Benagiano G. Joseph W. Goldzieher and the birth of hormonal contraception. Contraception 2010; 82:119–124.
   PubMed Web of Science ®Google Scholar
• Goldzieher JW, Green JA. The polycystic ovary. I. clinical and histologic features. J Clin Endocrinol Metab. 1962;22:325–338.
   PubMed Web of Science ®Google Scholar
• Goldzieher JW, Axelrod LR. The polycystic ovary. II. Urinary steroid excretion. J Clin Endocrinol Metab. 1962;22:425–430.
   PubMed Web of Science ®Google Scholar
• Axelrod LR, Goldzieher JW. The polycystic ovary. III. Steroid biosynthesis in normal and polycystic ovarian tissue. J Clin Endocrinol Metab. 1962;22:431–440.
   PubMed Web of Science ®Google Scholar
• Zawadzki JK, Dunaif A, Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, et al., eds. Polycystic ovary syndrome. Boston: Blackwell Scientific; 1992. p. 377–384.
   Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;8:19–25.
   Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41–47.
   PubMed Web of Science ®Google Scholar
• Azziz R. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab. 2006;91:781–785.
   PubMed Web of Science ®Google Scholar
• Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 1935;29:181–191.
   Google Scholar
• Chen ZJ, Zhao H, He L, et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet. 2011;43:55–59.
   PubMed Web of Science ®Google Scholar
• Shi Y, Zhao H, Shi Y, et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat Genet. 2012;44:1020–1025.
   PubMed Web of Science ®Google Scholar
• Hayes MG, Urbanek M, Ehrmann DA, et al. Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nat Commun. 2015;6:7502.
   PubMed Web of Science ®Google Scholar
• Day F, Karaderi T, Jones MR, et al. Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. PLOS Genet. 2018;14:e1007813.
   PubMed Web of Science ®Google Scholar
• Zañartu J, Rice-Wray E, Goldzieher JW. Fertility control with long-acting injectable steroids. A preliminary report. Obstet Gynecol. 1966;28:513–515.
   PubMed Web of Science ®Google Scholar
• Goldzieher JW, Moses LE, Ellis LT, A field trial with a physiological method of conception control. In: Kiser CV, editor. Conference on research in family planning, New York, 1960. Princeton (NJ): Princeton University Press; 1962. p. 351–356.
   Google Scholar
• Goldzieher JW, Moses LE, Ellis LT. Study of norethindrone in contraception. JAMA. 1962;180:359–361.
   Web of Science ®Google Scholar
• Goldzieher JW, Rice-Wray E, Schulz-Contreras M, et al. Fertility following termination of contraception with norethindrone. Endometrial morphology and conception rate. Am J Obstet Gynecol. 1962;84:1474–1477.
   Web of Science ®Google Scholar
• Goldzieher JW. Clinical evaluation of contraceptives: a great responsibility. Yearbook Gynecol 1965–1966:371–374.
   Google Scholar
• Realini JP, Goldzieher JW. Oral contraceptives and cardiovascular disease: a critique of the epidemiologic studies. Am J Obstet Gynecol. 1985;152:729–798.
   PubMed Web of Science ®Google Scholar
• Royal College of General Practitionrs. Oral contraception and thromboembolic disease. J Roy Coll Gen Pract. 1967;13:267–279.
   PubMedGoogle Scholar
• Lidegaard Ø, Nielsen LH, Skovlund CW, et al. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001–2009. BMJ. 2011;343:d6423.
   PubMed Web of Science ®Google Scholar
• Practice Committee of the American Society for Reproductive Medicine Combined hormonal contraception and the risk of venous thromboembolism: a guideline. Fertil Steril. 2017;107:43–51.
   PubMed Web of Science ®Google Scholar
• Parkin L, Skegg DC, Wilson M, et al. Oral contraceptives and fatal pulmonary embolism. Lancet. 2000;355:2133–2134.
   PubMed Web of Science ®Google Scholar
• Inman WHW, Vessey MP. Investigation of deaths from pulmonary, coronary and cerebral thrombosis and thromboembolism in women of childbearing age. Brit Med J. 1968;2:193–199.
   PubMed Web of Science ®Google Scholar
• Roach RE, Helmerhorst FM, Lijfering WM, et al. Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke. Cochrane Database Syst Rev. 2015;CD011054.
   PubMed Web of Science ®Google Scholar
• Tanis BC, van den Bosch MA, Kemmeren JM, et al. Oral contraceptives and the risk of myocardial infarction. N Engl J Med. 2001;345:1787–1793.
   PubMed Web of Science ®Google Scholar
• Beral V. Mortality among oral-contraceptive users. Royal College of General Practitioners' oral contraception study. Lancet. 1977;2:727–731.
   PubMed Web of Science ®Google Scholar
• Belsey MA, Russel Y, Kinnear K. Cardiovascular disease and oral contraceptives: a reappraisal of vital statistics. Fam Plann Perspect. 1979;2:84–89.
   Google Scholar
• Porter JB, Jick H, Walker AM. Mortality among oral contraceptive users. Obstet Gynecol. 1987;70:29–32.
   PubMed Web of Science ®Google Scholar
• Hannaford PC, Iversen L, Macfarlane TV, et al. Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners' Oral Contraception Study. BMJ. 2010;340:c927.
   PubMed Web of Science ®Google Scholar